BE889640A - Preparation thromboplastique a base de proteines humaines et son procede d'obtention - Google Patents

Preparation thromboplastique a base de proteines humaines et son procede d'obtention

Info

Publication number
BE889640A
BE889640A BE0/205416A BE205416A BE889640A BE 889640 A BE889640 A BE 889640A BE 0/205416 A BE0/205416 A BE 0/205416A BE 205416 A BE205416 A BE 205416A BE 889640 A BE889640 A BE 889640A
Authority
BE
Belgium
Prior art keywords
thromboplastic
human proteins
preparation based
obtaining same
obtaining
Prior art date
Application number
BE0/205416A
Other languages
English (en)
Original Assignee
Immuno A G Fur Chemisch Medizi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno A G Fur Chemisch Medizi filed Critical Immuno A G Fur Chemisch Medizi
Publication of BE889640A publication Critical patent/BE889640A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BE0/205416A 1980-07-22 1981-07-15 Preparation thromboplastique a base de proteines humaines et son procede d'obtention BE889640A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0378180A ATA378180A (de) 1980-07-22 1980-07-22 Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen

Publications (1)

Publication Number Publication Date
BE889640A true BE889640A (fr) 1981-11-03

Family

ID=3555339

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/205416A BE889640A (fr) 1980-07-22 1981-07-15 Preparation thromboplastique a base de proteines humaines et son procede d'obtention

Country Status (17)

Country Link
US (1) US4395396A (fr)
AR (1) AR227194A1 (fr)
AT (2) ATA378180A (fr)
BE (1) BE889640A (fr)
CH (1) CH646061A5 (fr)
DE (1) DE3127318A1 (fr)
DK (1) DK155500C (fr)
ES (1) ES8203610A1 (fr)
FI (1) FI77048C (fr)
FR (1) FR2487199A1 (fr)
GB (1) GB2080312B (fr)
HU (1) HU188298B (fr)
IT (1) IT1142032B (fr)
LU (1) LU83499A1 (fr)
NL (1) NL190268C (fr)
NO (1) NO157245C (fr)
SE (1) SE460174B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE36457T1 (de) * 1983-05-02 1988-09-15 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern.
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
FR2622108B1 (fr) * 1987-10-23 1990-03-02 Lille Transfusion Sanguine Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
DK0573605T3 (da) * 1991-03-01 2001-01-02 Rhone Poulenc Rorer Int Fremstilling af faktor IX
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
FR2711371B1 (fr) * 1993-10-18 1995-12-29 Aetsrn Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
ES2241030T3 (es) * 1996-03-20 2005-10-16 Baxter Aktiengesellschaft Preparado farmaceutico para el tratamiento de alteraciones de la coagulacion sanguinea.
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
ES2160410T3 (es) 1997-04-08 2001-11-01 Baxter Ag Preparados de complejos de protrombina inmunotolerantes.
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT411997B (de) 1999-09-14 2004-08-26 Baxter Ag Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
CA2425935C (fr) 2000-11-07 2011-03-29 Cryolife, Inc. Biomateriaux semblables a la mousse expansibles et procedes
EP1523327A1 (fr) * 2002-07-23 2005-04-20 Bio-Products & Bio-Engineering Aktiengesellschaft Preparations de principes actifs pharmaceutiques et medicaments generant ou contenant de la thrombine
RS52080B (sr) * 2002-07-23 2012-06-30 Bio & Bio Licensing Sa Farmaceutski aktivna supstanca preparata i lekova koji su u stanju da stvaraju trombin i/ili da sadrže trombin
US7297336B2 (en) 2003-09-12 2007-11-20 Baxter International Inc. Factor IXa specific antibodies displaying factor VIIIa like activity
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492108A1 (de) 1964-05-04 1969-10-02 Rohm & Haas Verfahren zur Entfernung von Viren aus Blut waehrend der Entnahme oder UEbertragung
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
JPS52125609A (en) 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
US4081432A (en) 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
EP0044343B1 (fr) * 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Compositions therapeutiques contenant de la prothrombine et procede de production de facteurs de coagulation du sang agissant enzymatiquement, a partir de fractions sanguines contenant de la prothrombine
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them

Also Published As

Publication number Publication date
FI77048C (fi) 1989-01-10
HU188298B (en) 1986-03-28
NO157245B (no) 1987-11-09
DK318581A (da) 1982-01-23
DK155500B (da) 1989-04-17
DK155500C (da) 1989-08-07
ES504000A0 (es) 1982-04-16
IT1142032B (it) 1986-10-08
NO812500L (no) 1982-01-25
IT8123070A0 (it) 1981-07-22
FI77048B (fi) 1988-09-30
NO157245C (no) 1988-02-24
LU83499A1 (de) 1981-10-29
CH646061A5 (de) 1984-11-15
FI812295L (fi) 1982-01-23
ES8203610A1 (es) 1982-04-16
FR2487199A1 (fr) 1982-01-29
AR227194A1 (es) 1982-09-30
AT368883B (de) 1982-11-25
ATA378180A (de) 1982-04-15
NL190268B (nl) 1993-08-02
US4395396A (en) 1983-07-26
GB2080312A (en) 1982-02-03
DE3127318A1 (de) 1982-04-15
NL190268C (nl) 1994-01-03
DE3127318C2 (fr) 1988-07-28
SE8103759L (sv) 1982-01-23
GB2080312B (en) 1983-12-21
NL8103329A (nl) 1982-02-16
SE460174B (sv) 1989-09-18
FR2487199B1 (fr) 1984-11-16

Similar Documents

Publication Publication Date Title
BE889640A (fr) Preparation thromboplastique a base de proteines humaines et son procede d'obtention
RO88582A (fr) Procede d'obtention d'un proteine heterologique
FR2497967B1 (fr) Lentille de contact et son procede de preparation
FR2499414B1 (fr) Production d'anticorps proteiniques humains
LU79162A1 (fr) Benzylimidazole derivatives-herbicides et procede d'obtention
BE888578A (fr) Composition de sec-butylbiphenyle et procede d'obtention,
IT1123137B (it) "3",4"-diaciltilosina e procedimento per la sua produzione
FR2618351B1 (fr) Emulsions gelifiees transparentes et leur procede d'obtention
FR2630306B1 (fr) Cheveu artificiel et son procede de preparation
FR2598907B1 (fr) Cheveu artificiel pour l'implantation de cheveux et son procede de preparation
FR2581664B1 (fr) Appareil d'etirage
FR2648318B1 (fr) Fromages hyposodes et leur procede d'obtention
FR2540107B1 (fr) Nouveaux derives d'halogenobenzophenone-oxime, utilisation en therapeutique et procede de preparation
FR2637806B1 (fr) Appareil et procede d'obtention de serum de veau
RO79917A2 (fr) Derives de la theophyline et procede d'obtention
FR2642653B1 (fr) Appareil d'electrotherapie
RO83590A2 (fr) Fourrage avec proteines de selles et procede d'obtention
FR2492663B1 (fr) Produit medicamenteux regulateur du t-systeme de l'immunite et son procede de preparation
RO93008A2 (fr) Copolymeres en base de cicyclopentadiene et procede d'obtention
RO93136A2 (fr) Procede d'obtention de la cryolithe
RO80032A2 (fr) Procede d'obtention de la hormone coriogonadotrope humaine
FR2581990B1 (fr) Derives allylbenzenique utilisables pour l'obtention de pesticides et leur procede de preparation
RO81118A2 (fr) Adjoint progesterone-histaminique et procede d'obtention
RO80055A2 (fr) Composition medicamenteuse antiacneique,antiseboreique et antiactinique et procede d'obtention
RO91191A2 (fr) Procede d'obtention du xanthydrol

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: IMMUNO A.G. FUR CHEMISCH-MEDIZINISCHE PRODUKTE

Effective date: 20010715